(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: TECFIDERA (dimethyl fumarate, BG-12, Fumaderm) ***************************************************** #Post#: 3000-------------------------------------------------- (Abst.) PML in Tecfidera-treated MS patients By: agate Date: August 20, 2020, 2:33 pm --------------------------------------------------------- From PubMed (August 20, 2020)--"Progressive multifocal leucoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients": (HTM) https://pubmed.ncbi.nlm.nih.gov/32808554/ The researchers are affiliated with the Consortium of Multiple Sclerosis Centers (CMSC) and the University of Michigan. #Post#: 3839-------------------------------------------------- PML outcomes in MS patients treated with dimethyl fumarate By: agate Date: November 14, 2022, 1:41 am --------------------------------------------------------- Some Biogen researchers have published a report on MS patients being treated with dimethyl fumarate who developed PML. From Multiple Sclerosis Journal (November 10, 2022)--"Progressive multifocal leucoencephalopathy outcomes in patients with multiple sclerosis treated with dimethyl fumarate": (HTM) https://journals.sagepub.com/doi/full/10.1177/20552173221132469 #Post#: 3957-------------------------------------------------- Authors' correction to the previously cited article By: agate Date: March 8, 2023, 1:35 am --------------------------------------------------------- The authors of the article in the previous post in this thread have published a correction (Multiple Sclerosis Journal, February 27, 2023): (HTM) https://journals.sagepub.com/doi/full/10.1177/20552173231160312 *****************************************************